1. Home
  2. DTI vs ABOS Comparison

DTI vs ABOS Comparison

Compare DTI & ABOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Drilling Tools International Corporation

DTI

Drilling Tools International Corporation

HOLD

Current Price

$3.04

Market Cap

152.7M

Sector

Industrials

ML Signal

HOLD

Logo Acumen Pharmaceuticals Inc.

ABOS

Acumen Pharmaceuticals Inc.

HOLD

Current Price

$2.29

Market Cap

182.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DTI
ABOS
Founded
1984
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Metal Fabrications
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
152.7M
182.0M
IPO Year
2021
2021

Fundamental Metrics

Financial Performance
Metric
DTI
ABOS
Price
$3.04
$2.29
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$8.00
AVG Volume (30 Days)
361.1K
275.8K
Earning Date
05-07-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$154,446,000.00
N/A
Revenue This Year
$2.05
N/A
Revenue Next Year
$4.48
N/A
P/E Ratio
N/A
N/A
Revenue Growth
1.59
N/A
52 Week Low
$1.65
$0.99
52 Week High
$4.69
$3.60

Technical Indicators

Market Signals
Indicator
DTI
ABOS
Relative Strength Index (RSI) 42.27 37.17
Support Level $2.82 $2.19
Resistance Level $3.15 $2.42
Average True Range (ATR) 0.20 0.13
MACD -0.01 -0.01
Stochastic Oscillator 29.71 4.21

Price Performance

Historical Comparison
DTI
ABOS

About DTI Drilling Tools International Corporation

Drilling Tools International Corp is an oilfield services company that designs, engineers, and manufactures rental-focused tools used in onshore and offshore horizontal and directional drilling operations, as well as solutions across the well life cycle. It operates through two geographic segments: Western Hemisphere and Eastern Hemisphere. The Western Hemisphere, which generates the majority of revenue, provides downhole drilling tools and rental services for onshore and offshore operations across North America and Latin America, supported by service centers in the U.S. and Canada. The Eastern Hemisphere covers Europe, the Middle East, and Asia-Pacific, where the company offers drilling and well lifecycle solutions through international service centers across the EMEA and APAC regions.

About ABOS Acumen Pharmaceuticals Inc.

Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believes to be a key underlying cause of Alzheimer's disease. The company's drug candidate, ACU193, is a subclass monoclonal antibody that selectively targets amyloid-beta oligomers. The product pipelines include: ALTITUDE-AD; and INTERCEPT-AD.

Share on Social Networks: